6MK:FRA
Merck & Co Inc
€129.88
arrow_upward
+0.19%(+0.24) 1D
Sep 25, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 6MK...
Open
€130.04
High
€130.04
Low
€129.66
Mkt. cap
367.07B
Avg. vol.
806.00
Volume
286.00
52-wk high
€134.54
52-wk low
€66.40
No. of employees
74K
Open
€130.04
High
€130.04
Low
€129.66
Mkt. cap
367.07B
Avg. vol.
806.00
Volume
286.00
52-wk high
€134.54
52-wk low
€66.40
No. of employees
74K
News stories
From web sources and news partners
Investing.com Nigeria
·
1 hour ago
Form 4 Merck For: 26 September By Investing.com
Yahoo Finance Singapore
·
21 hours ago
Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval
AD HOC NEWS
·
1 day ago
Merck & Co. stock is last at USD 147.97, down 0.01 percent in New York trading
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com